[1]
R. K. Shahi, R. Rai, and P. Nigam, “Prospective study of comparing efficacy of Continuous Subcutaneous Insulin Infusion of Insulin Aspart versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in patients of Type 1 Diabetic mellitus”, Int. J. Heal. Clin. Res., vol. 3, no. 3, pp. 1–4, Jul. 2020.